Data gathered: October 1
Alternative Data for Abbott Laboratories
About Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
| Price | $113.36 |
| Target Price | Sign up |
| Volume | 1,140,000 |
| Market Cap | $196B |
| Year Range | $100.07 - $119.71 |
| Dividend Yield | 1.96% |
| PE Ratio | 35.47 |
| Analyst Rating | 79% buy |
| Earnings Date | October 16 '24 |
| Industry | Health Care Services |
In the news
 |
Founders Financial Alliance LLC Purchases 467 Shares of Abbott Laboratories (NYSE:ABT)October 1 - ETF Daily News |
|
Granite Bay Wealth Management LLC Invests $4.70 Million in Abbott Laboratories (NYSE:ABT)October 1 - ETF Daily News |
 |
B. Riley Wealth Advisors Inc. Has $6.10 Million Stake in Abbott Laboratories (NYSE:ABT)October 1 - Biztoc.com |
|
Covington Investment Advisors Inc. Sells 740 Shares of Abbott Laboratories (NYSE:ABT)September 30 - ETF Daily News |
|
3,213 Shares in Abbott Laboratories (NYSE:ABT) Bought by Wellington Wealth Strategies LLC.September 30 - ETF Daily News |
|
William B. Walkup & Associates Inc. Makes New Investment in Abbott Laboratories (NYSE:ABT)September 30 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 10.4B | 8.01B | 2.37B | 1.3B | 2.14B | 1.140 |
| Q1 '24 | 9.82B | 7.9B | 1.92B | 1.23B | 2.05B | 0.980 |
| Q4 '23 | 10.1B | 8.26B | 1.8B | 1.59B | 2.44B | 1.190 |
| Q3 '23 | 9.99B | 7.82B | 2.16B | 1.44B | 2.33B | 1.140 |
| Q2 '23 | 9.8B | 7.72B | 2.08B | 1.38B | 2.29B | 1.080 |
Insider Transactions View All
| Ford Robert B filed to sell 220,059 shares at $116.9. September 13 '24 |
| Ford Robert B filed to sell 281,439 shares at $116. September 13 '24 |
| MCCOY JOHN A. JR. filed to sell 18,681 shares at $114.8. September 4 '24 |
| Funck, Jr. Robert E. filed to sell 211,341 shares at $104.6. May 14 '24 |
| Earnhardt Lisa D filed to sell 61,462 shares at $106.3. May 8 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Sep 11, 24 | Buy | $1K - $15K |
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Jared Moskowitz |
Aug 19, 24 | Buy | $1K - $15K |
Read more about Abbott Laboratories (ABT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Abbott Laboratories?
The Market Cap of Abbott Laboratories is $196B.
What is Abbott Laboratories' PE Ratio?
As of today, Abbott Laboratories' PE (Price to Earnings) ratio is 35.47.
When does Abbott Laboratories report earnings?
Abbott Laboratories will report its next earnings on October 16 '24.
What is the current stock price of Abbott Laboratories?
Currently, the price of one share of Abbott Laboratories stock is $113.36.
How can I analyze the ABT stock price chart for investment decisions?
The ABT stock price chart above provides a comprehensive visual representation of Abbott Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Abbott Laboratories shares. Our platform offers an up-to-date ABT stock price chart, along with technical data analysis and alternative data insights.
Does ABT offer dividends to its shareholders?
Yes, Abbott Laboratories (ABT) offers dividends to its shareholders, with a dividend yield of 1.96%. This dividend yield represents Abbott Laboratories' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Abbott Laboratories in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Abbott Laboratories?
Some of the similar stocks of Abbott Laboratories are HCA Healthcare, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.
.